Vener C - Search Results

1

First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis.

Vener C, Banzi R, Ambrogi F, Ferrero A, Saglio G, Pravettoni G, Sant M. Vener C, et al. Blood Adv. 2020 Jun 23;4(12):2723-2735. doi: 10.1182/bloodadvances.2019001329. Blood Adv. 2020. PMID: 32559295 Free PMC article.

2

Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates.

Minicozzi P, Cassetti T, Vener C, Sant M. Minicozzi P, et al. Among authors: vener c. Cancer Epidemiol. 2018 Aug;55:52-60. doi: 10.1016/j.canep.2018.04.011. Epub 2018 May 25. Cancer Epidemiol. 2018. PMID: 29777994

3

[A few hints to face Covid-19 pandemic in Italy].

Vener C, Ambrogi F, Sant M, Pravettoni G. Vener C, et al. Epidemiol Prev. 2020 Jul-Aug;44(4):201. doi: 10.19191/EP20.4.P201.049. Epidemiol Prev. 2020. PMID: 32921023 Italian. No abstract available.

4

The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars.

Mazzoni D, Vener C, Mazzocco K, Monzani D, Pravettoni G. Mazzoni D, et al. Among authors: vener c. Front Psychol. 2021 Jan 27;12:605643. doi: 10.3389/fpsyg.2021.605643. eCollection 2021. Front Psychol. 2021. PMID: 33584474 Free PMC article. No abstract available.

5

[Why should negative results studies be published?].

Vener C, Ambrogi F, Sant M, Pravettoni G. Vener C, et al. Epidemiol Prev. 2021 Jul-Aug;45(4):226. doi: 10.19191/EP21.4.P226.075. Epidemiol Prev. 2021. PMID: 34549562 Italian. No abstract available.

6

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.

Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M; EUROCARE-6 Working Group. Vener C, et al. Front Oncol. 2022 Jul 14;12:892684. doi: 10.3389/fonc.2022.892684. eCollection 2022. Front Oncol. 2022. PMID: 35912208 Free PMC article.

7

Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients.

Cutica I, Riva S, Orlandi EM, Iurlo A, Vener C, Elena C, Bucelli C, Cattaneo D, Tomezzoli E, Pravettoni G. Cutica I, et al. Among authors: vener c. Patient Prefer Adherence. 2022 Oct 31;16:2963-2975. doi: 10.2147/PPA.S369326. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36338243 Free PMC article.

8

Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.

Vener C, Fracchiolla NS, Gianelli U, Calori R, Radaelli F, Iurlo A, Caberlon S, Gerli G, Boiocchi L, Deliliers GL. Vener C, et al. Blood. 2008 Feb 15;111(4):1862-5. doi: 10.1182/blood-2007-09-112953. Epub 2007 Nov 20. Blood. 2008. PMID: 18029552 Free article.

9

Conjunctival hemorrhagic events associated with imatinib mesylate.

Radaelli F, Vener C, Ripamonti F, Iurlo A, Colombi M, Artoni A, Reda G, Deliliers GL. Radaelli F, et al. Among authors: vener c. Int J Hematol. 2007 Dec;86(5):390-3. doi: 10.1007/BF02983993. Int J Hematol. 2007. PMID: 18192104

10

Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia.

Porretti L, Farruggia P, Colombo FS, Cattaneo A, Ghilardi R, Mirra N, Notarangelo LD, Martire B, Trombetta E, Milani S, Vener C, Rebulla P. Porretti L, et al. Among authors: vener c. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26904. Epub 2017 Dec 12. Pediatr Blood Cancer. 2018. PMID: 29230955 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page